- Home
- CNEY vs CDIO Comparison
CNEY vs CDIO Comparison
Compare CNEY & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- CDIO
- Stock Information
- Founded
- CNEY 2018
- CDIO 2017
- Country
- CNEY China
- CDIO United States
- Employees
- CNEY N/A
- CDIO N/A
- Industry
- CNEY Major Chemicals
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CNEY Industrials
- CDIO Health Care
- Exchange
- CNEY Nasdaq
- CDIO Nasdaq
- Market Cap
- CNEY 8.0M
- CDIO 6.4M
- IPO Year
- CNEY 2021
- CDIO N/A
- Fundamental
- Price
- CNEY $2.34
- CDIO $3.79
- Analyst Decision
- CNEY
- CDIO
- Analyst Count
- CNEY 0
- CDIO 0
- Target Price
- CNEY N/A
- CDIO N/A
- AVG Volume (30 Days)
- CNEY 372.1K
- CDIO 23.0K
- Earning Date
- CNEY 01-01-0001
- CDIO 11-12-2025
- Dividend Yield
- CNEY N/A
- CDIO N/A
- EPS Growth
- CNEY N/A
- CDIO N/A
- EPS
- CNEY N/A
- CDIO N/A
- Revenue
- CNEY $50,957,974.00
- CDIO $19,507.00
- Revenue This Year
- CNEY N/A
- CDIO $1,434.82
- Revenue Next Year
- CNEY N/A
- CDIO $4,661.91
- P/E Ratio
- CNEY N/A
- CDIO N/A
- Revenue Growth
- CNEY N/A
- CDIO N/A
- 52 Week Low
- CNEY $1.56
- CDIO $3.22
- 52 Week High
- CNEY $31.75
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- CNEY 51.98
- CDIO 49.19
- Support Level
- CNEY $1.56
- CDIO $3.58
- Resistance Level
- CNEY $2.57
- CDIO $3.98
- Average True Range (ATR)
- CNEY 0.30
- CDIO 0.24
- MACD
- CNEY 0.01
- CDIO 0.03
- Stochastic Oscillator
- CNEY 71.76
- CDIO 61.04
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.